<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet13161</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-13161</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Ожирение, сахарный диабет и витамин D</article-title><trans-title-group xml:lang="en"><trans-title>Obesity, diabetes and vitamin D</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6539-466X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пигарова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pigarova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пигарова Екатерина Александровна - д.м.н., вед. научн. сотрудник отделения нейроэндокринологии, директор Института высшего и дополнительного профессионального образования.</p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11</p><p>Scopus Author ID 55655098500; ResearcherId T-9424-2018</p></bio><bio xml:lang="en"><p>Ekaterina A. Pigarova - MD, PhD, senior researcher at the Neuroendocrinology and osteopathies Department.</p><p>11 Dm. Ulyanova street, 117036 Moscow</p><p>Scopus Author ID 55655098500; ResearcherId T-9424-2018</p></bio><email xlink:type="simple">kpigarova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0327-4619</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дзеранова</surname><given-names>Л. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzeranova</surname><given-names>L. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дзеранова Лариса Константиновна - д.м.н.</p><p>117036, Москва, ул. Дмитрия Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Larisa K. Dzeranova - MD, PhD.</p><p>11 Dm. Ulyanova street, 117036 Moscow</p></bio><email xlink:type="simple">dzeranovalk@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ эндокринологии» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>26</day><month>09</month><year>2024</year></pub-date><volume>21</volume><issue>3</issue><fpage>316</fpage><lpage>324</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пигарова Е.А., Дзеранова Л.К., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Пигарова Е.А., Дзеранова Л.К.</copyright-holder><copyright-holder xml:lang="en">Pigarova E.A., Dzeranova L.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/13161">https://www.omet-endojournals.ru/jour/article/view/13161</self-uri><abstract><p>Дефицит и недостаточность витамина D широко распространены в глобальном масштабе, при этом в их развитии играют роль многочисленные факторы, такие как ограниченное воздействие солнечного света, недостаточное питание, заболевания ЖКТ, а также ожирение, которое затрагивает примерно 39% взрослого населения мира. Помимо своей канонической роли в функционировании скелета, витамин D модулирует адипогенез, а также секрецию и действие инсулина при диабете. Недостаточность витамина D, обусловленная ожирением, вероятно, связана со снижением биодоступности витамина D посредством синтеза в коже и из пищевых источников, что связано с его отложениями в жировых депо организма, тогда как прямое действие на адипогенез, по-видимому, реализуется в критические периоды жизни (пре- и постнатальные периоды). Витамин D напрямую регулирует гены, участвующие в путях секреции и действии инсулина. Широкая мировая распространенность дефицита витамина D может быть связана с высокой заболеваемостью СД 2 типа (СД2), а нормализация уровня витамина D у пациентов может быть эффективной стратегией по замедлению прогрессирования СД2 и его осложнений.</p></abstract><trans-abstract xml:lang="en"><p>Vitamin D deficiency and insufficiency are widespread globally with multiple factors playing a role in their development. Such as limited exposure to sunlight, poor nutrition, gastrointestinal diseases, and obesity, which affects approximately 39% of the world’s adult population. In addition to its canonical role in skeletal function, vitamin D modulates adipogenesis, insulin secretion, and action in diabetes. Vitamin D deficiency due to obesity is likely due to decreased bioavailability of vitamin D through synthesis in the skin and from dietary sources, which is associated with its deposition in body fat depots. While a direct effect on adipogenesis appears to be realized during critical periods of life (pre- and postnatal periods). Vitamin D directly regulates genes involved pathways of insulin secretion and action. The high worldwide prevalence of vitamin D deficiency may be associated with the high incidence of type 2 diabetes, and normalizing vitamin D levels in patients may be an effective strategy to slow the progression of type 2 diabetes and its complications.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>витамин D</kwd><kwd>колекальциферол</kwd><kwd>ожирение</kwd><kwd>сахарный диабет</kwd><kwd>высокодозный витамин D</kwd></kwd-group><kwd-group xml:lang="en"><kwd>vitamin D</kwd><kwd>cholecalciferol</kwd><kwd>obesity</kwd><kwd>diabetes mellitus</kwd><kwd>high-dose vitamin D</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Тема государственного задания «Новые технологии диагностики и дифференциальной диагностики первичного и вторичного остеопороза на фоне эндокринопатий и орфанных заболеваний скелета».</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Fact Sheet: Obesity and Overweight. Geneva, Switzerland: World Health Organization; 2016</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Fact Sheet: Obesity and Overweight. Geneva, Switzerland: World Health Organization; 2016</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Saponaro F, Saba A, Zucchi R. An update on vitamin d metabolism. Int J Mol Sci. 2020. doi: https://doi.org/10.3390/ijms21186573</mixed-citation><mixed-citation xml:lang="en">Saponaro F, Saba A, Zucchi R. An update on vitamin d metabolism. Int J Mol Sci. 2020. doi: https://doi.org/10.3390/ijms21186573</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Pigarova EA, Petrushkina AA. Non-classical effects of vitamin D. Osteoporosis and Bone Diseases. 2017;20(3):90-101. doi: https://doi.org/10.14341/osteo2017390-101</mixed-citation><mixed-citation xml:lang="en">Pigarova EA, Petrushkina AA. Non-classical effects of vitamin D. Osteoporosis and Bone Diseases. 2017;20(3):90-101. doi: https://doi.org/10.14341/osteo2017390-101</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Pigarova EA, Dzeranova LК, Yatsenko DA. Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases. Obesity and metabsm. 2022;19(1):123-133. doi: https://doi.org/10.14341/omet12835</mixed-citation><mixed-citation xml:lang="en">Pigarova EA, Dzeranova LК, Yatsenko DA. Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases. Obesity and metabsm. 2022;19(1):123-133. doi: https://doi.org/10.14341/omet12835</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Carlberg C. Nutrigenomics of Vitamin D. Nutrients. 2019;11(3):676. doi: https://doi.org/10.3390/nu11030676</mixed-citation><mixed-citation xml:lang="en">Carlberg C. Nutrigenomics of Vitamin D. Nutrients. 2019;11(3):676. doi: https://doi.org/10.3390/nu11030676</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pigarova EA, Rozhinskaya LYa, Belaya JE, Dzeranova LK, et al. Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults. Problems of Endocrinology. 2016;62(4):60-84. doi: https://doi.org/10.14341/probl201662460-84</mixed-citation><mixed-citation xml:lang="en">Pigarova EA, Rozhinskaya LYa, Belaya JE, Dzeranova LK, et al. Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults. Problems of Endocrinology. 2016;62(4):60-84. doi: https://doi.org/10.14341/probl201662460-84</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Povaliaeva A, Pigarova E, Zhukov A, Bogdanov V, Dzeranova L, et al. Evaluation of Vitamin D Metabolism in Patients with Type 1 Diabetes Mellitus in the Setting of Cholecalciferol Treatment. Nutrients. 2020;12(12):3873. doi: https://doi.org/10.3390/nu12123873</mixed-citation><mixed-citation xml:lang="en">Povaliaeva A, Pigarova E, Zhukov A, Bogdanov V, Dzeranova L, et al. Evaluation of Vitamin D Metabolism in Patients with Type 1 Diabetes Mellitus in the Setting of Cholecalciferol Treatment. Nutrients. 2020;12(12):3873. doi: https://doi.org/10.3390/nu12123873</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Szymczak-Tomczak A, Ratajczak AE, Kaczmarek-Ryś M, Hryhorowicz S, Rychter AM, et al. Pleiotropic Effects of Vitamin D in Patients with Inflammatory Bowel Diseases. J Clin Med. 2022;11(19):5715. doi: https://doi.org/10.3390/jcm11195715</mixed-citation><mixed-citation xml:lang="en">Szymczak-Tomczak A, Ratajczak AE, Kaczmarek-Ryś M, Hryhorowicz S, Rychter AM, et al. Pleiotropic Effects of Vitamin D in Patients with Inflammatory Bowel Diseases. J Clin Med. 2022;11(19):5715. doi: https://doi.org/10.3390/jcm11195715</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Marazziti D, Parra E, Palermo S, Barberi FM, Buccianelli B, et al. Vitamin D: A Pleiotropic Hormone with Possible Psychotropic Activities. Curr Med Chem. 2021;28(19):3843-3864. doi: https://doi.org/10.2174/0929867328666201210104701</mixed-citation><mixed-citation xml:lang="en">Marazziti D, Parra E, Palermo S, Barberi FM, Buccianelli B, et al. Vitamin D: A Pleiotropic Hormone with Possible Psychotropic Activities. Curr Med Chem. 2021;28(19):3843-3864. doi: https://doi.org/10.2174/0929867328666201210104701</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitamin D3: Genomic and non-genomic mechanisms. Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism. 2011;25(4):543-559. doi: https://doi.org/10.1016/j.beem.2011.05.010</mixed-citation><mixed-citation xml:lang="en">Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitamin D3: Genomic and non-genomic mechanisms. Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism. 2011;25(4):543-559. doi: https://doi.org/10.1016/j.beem.2011.05.010</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mizwicki MT, Norman AW. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Science Signaling. 2009;2(75):re4-re4. doi: https://doi.org/10.1126/scisignal.275re4</mixed-citation><mixed-citation xml:lang="en">Mizwicki MT, Norman AW. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Science Signaling. 2009;2(75):re4-re4. doi: https://doi.org/10.1126/scisignal.275re4</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Huhtakangas JA, Olivera CJ, Bishop JE, et al. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1α,25(OH)2-vitamin D3 in vivo and in vitro. Molecular Endocrinology. 2004;18(11). doi: https://doi.org/10.1210/me.2004-0116</mixed-citation><mixed-citation xml:lang="en">Huhtakangas JA, Olivera CJ, Bishop JE, et al. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1α,25(OH)2-vitamin D3 in vivo and in vitro. Molecular Endocrinology. 2004;18(11). doi: https://doi.org/10.1210/me.2004-0116</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nemere I, Safford SE, Rohe B, et al. Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS) binding protein. The Journal of Steroid Biochemistry and Molecular Biology. 2004;89-90:281-285. doi: https://doi.org/10.1016/j.jsbmb.2004.03.031</mixed-citation><mixed-citation xml:lang="en">Nemere I, Safford SE, Rohe B, et al. Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS) binding protein. The Journal of Steroid Biochemistry and Molecular Biology. 2004;89-90:281-285. doi: https://doi.org/10.1016/j.jsbmb.2004.03.031</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Park CY, Han SN. Vitamin D and obesity. Adv Food Nutr Res. 2024;109:221-247. doi: https://doi.org/10.1016/bs.afnr.2023.12.006</mixed-citation><mixed-citation xml:lang="en">Park CY, Han SN. Vitamin D and obesity. Adv Food Nutr Res. 2024;109:221-247. doi: https://doi.org/10.1016/bs.afnr.2023.12.006</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Snegarova V, Naydenova D. Vitamin D: a Review of its Effects on Epigenetics and Gene Regulation. Folia Med (Plovdiv). 2020;62(4):662-667. doi: https://doi.org/10.3897/folmed.62.e50204</mixed-citation><mixed-citation xml:lang="en">Snegarova V, Naydenova D. Vitamin D: a Review of its Effects on Epigenetics and Gene Regulation. Folia Med (Plovdiv). 2020;62(4):662-667. doi: https://doi.org/10.3897/folmed.62.e50204</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol. 2000;16:145–171. doi: https://dx.doi.org/10.1146/annurev.cellbio.16.1.145</mixed-citation><mixed-citation xml:lang="en">Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol. 2000;16:145–171. doi: https://dx.doi.org/10.1146/annurev.cellbio.16.1.145</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Dix CF, Barcley JL, Wright ORL. The role of vitamin D in adipogenesis. Nutr Rev. 2018;76(1):47-59. doi: https://doi.org/10.1093/nutrit/nux056. Erratum in: Nutr Rev. 2019;77(9):662. doi: https://doi.org/10.1093/nutrit/nuz060</mixed-citation><mixed-citation xml:lang="en">Dix CF, Barcley JL, Wright ORL. The role of vitamin D in adipogenesis. Nutr Rev. 2018;76(1):47-59. doi: https://doi.org/10.1093/nutrit/nux056. Erratum in: Nutr Rev. 2019;77(9):662. doi: https://doi.org/10.1093/nutrit/nuz060</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Sarjeant K, Stephens JM. Adipogenesis. Cold Spring Harb Perspect Biol. 2012;4:a008417; Dix CF, Barcley JL, Wright ORL. The role of vitamin D in adipogenesis. Nutr Rev. 2018;76(1):47-59. doi: https://doi.org/10.1093/nutrit/nux056. Erratum in: Nutr Rev. 2019;77(9):662. doi: https://doi.org/10.1093/nutrit/nuz060</mixed-citation><mixed-citation xml:lang="en">Sarjeant K, Stephens JM. Adipogenesis. Cold Spring Harb Perspect Biol. 2012;4:a008417; Dix CF, Barcley JL, Wright ORL. The role of vitamin D in adipogenesis. Nutr Rev. 2018;76(1):47-59. doi: https://doi.org/10.1093/nutrit/nux056. Erratum in: Nutr Rev. 2019;77(9):662. doi: https://doi.org/10.1093/nutrit/nuz060</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, et al. Dynamics of fat cell turnover in humans. Nature. 2008;453:783–787 doi: https://doi.org/10.1038/nature06902</mixed-citation><mixed-citation xml:lang="en">Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, et al. Dynamics of fat cell turnover in humans. Nature. 2008;453:783–787 doi: https://doi.org/10.1038/nature06902</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lee MJ, Wu Y, Fried SK. Adipose tissue remodeling in pathophysiology of obesity. Curr Opin Clin Nutr Metab Care. 2010;13:371–376; Nimitphong H, Park E, Lee MJ. Vitamin D regulation of adipogenesis and adipose tissue functions. Nutr Res Pract. 2020;14(6):553-567. doi: https://doi.org/10.4162/nrp.2020.14.6.553</mixed-citation><mixed-citation xml:lang="en">Lee MJ, Wu Y, Fried SK. Adipose tissue remodeling in pathophysiology of obesity. Curr Opin Clin Nutr Metab Care. 2010;13:371–376; Nimitphong H, Park E, Lee MJ. Vitamin D regulation of adipogenesis and adipose tissue functions. Nutr Res Pract. 2020;14(6):553-567. doi: https://doi.org/10.4162/nrp.2020.14.6.553</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Revelo XS, Luck H, Winer S, Winer DA. Morphological and inflammatory changes in visceral adipose tissue during obesity. Endocr Pathol. 2014;25(1):93-101. doi: https://doi.org/10.1007/s12022-013-9288-1</mixed-citation><mixed-citation xml:lang="en">Revelo XS, Luck H, Winer S, Winer DA. Morphological and inflammatory changes in visceral adipose tissue during obesity. Endocr Pathol. 2014;25(1):93-101. doi: https://doi.org/10.1007/s12022-013-9288-1</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Abate N, Chandalia M. Role of subcutaneous adipose tissue in metabolic complications of obesity. Metab Syndr Relat Disord. 2012;10:319–320. doi: https://dx.doi.org/10.1089/met.2012.1502</mixed-citation><mixed-citation xml:lang="en">Abate N, Chandalia M. Role of subcutaneous adipose tissue in metabolic complications of obesity. Metab Syndr Relat Disord. 2012;10:319–320. doi: https://dx.doi.org/10.1089/met.2012.1502</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Pramyothin P, Biancuzzo RM, Lu ZR, et al. Vitamin D in adipose tissue and serum 25-hydroxyvitamin D after roux-en-Y gastric bypass. Obesity (Silver Spring). 2011;19:2228–2234. doi: https://dx.doi.org/10.1038/oby.2011.170</mixed-citation><mixed-citation xml:lang="en">Pramyothin P, Biancuzzo RM, Lu ZR, et al. Vitamin D in adipose tissue and serum 25-hydroxyvitamin D after roux-en-Y gastric bypass. Obesity (Silver Spring). 2011;19:2228–2234. doi: https://dx.doi.org/10.1038/oby.2011.170</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Blum M, Dolnikowski G, Seyoum E, Harris SS, et al. Vitamin D(3) in fat tissue. Endocrine. 2008;33(1):90-4. doi: https://doi.org/10.1007/s12020-008-9051-4</mixed-citation><mixed-citation xml:lang="en">Blum M, Dolnikowski G, Seyoum E, Harris SS, et al. Vitamin D(3) in fat tissue. Endocrine. 2008;33(1):90-4. doi: https://doi.org/10.1007/s12020-008-9051-4</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Nimitphong H, Holick MF, Fried SK, Lee M-J. 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 Promote the Differentiation of Human Subcutaneous Preadipocytes. Makishima M, ed. PLoS One. 2012;7(12):e52171. doi: https://doi.org/10.1371/journal.pone.0052171</mixed-citation><mixed-citation xml:lang="en">Nimitphong H, Holick MF, Fried SK, Lee M-J. 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 Promote the Differentiation of Human Subcutaneous Preadipocytes. Makishima M, ed. PLoS One. 2012;7(12):e52171. doi: https://doi.org/10.1371/journal.pone.0052171</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Wamberg L, Christiansen T, Paulsen SK, et al. Expression of vitamin D-metabolizing enzymes in human adipose tissue—the effect of obesity and diet-induced weight loss. Int J Obes. 2013;37(5):651-657. doi: https://doi.org/10.1038/ijo.2012.112</mixed-citation><mixed-citation xml:lang="en">Wamberg L, Christiansen T, Paulsen SK, et al. Expression of vitamin D-metabolizing enzymes in human adipose tissue—the effect of obesity and diet-induced weight loss. Int J Obes. 2013;37(5):651-657. doi: https://doi.org/10.1038/ijo.2012.112</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Clemente-Postigo M, Muñoz-Garach A, Serrano M, et al. Serum 25-Hydroxyvitamin D and Adipose Tissue Vitamin D Receptor Gene Expression: Relationship With Obesity and Type 2 Diabetes. J Clin Endocrinol Metab. 2015;100(4):E591-E595. doi: https://doi.org/10.1210/jc.2014-3016</mixed-citation><mixed-citation xml:lang="en">Clemente-Postigo M, Muñoz-Garach A, Serrano M, et al. Serum 25-Hydroxyvitamin D and Adipose Tissue Vitamin D Receptor Gene Expression: Relationship With Obesity and Type 2 Diabetes. J Clin Endocrinol Metab. 2015;100(4):E591-E595. doi: https://doi.org/10.1210/jc.2014-3016</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen VT, Li X, Elli EF, et al. Vitamin D, inflammation, and relations to insulin resistance in premenopausal women with morbid obesity. Obesity. 2015. doi: https://doi.org/10.1002/oby.21131</mixed-citation><mixed-citation xml:lang="en">Nguyen VT, Li X, Elli EF, et al. Vitamin D, inflammation, and relations to insulin resistance in premenopausal women with morbid obesity. Obesity. 2015. doi: https://doi.org/10.1002/oby.21131</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Lu S, Cao ZB. Interplay between Vitamin D and Adipose Tissue: Implications for Adipogenesis and Adipose Tissue Function. Nutrients. 2023;15(22):4832. doi: https://doi.org/10.3390/nu15224832</mixed-citation><mixed-citation xml:lang="en">Lu S, Cao ZB. Interplay between Vitamin D and Adipose Tissue: Implications for Adipogenesis and Adipose Tissue Function. Nutrients. 2023;15(22):4832. doi: https://doi.org/10.3390/nu15224832</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Pannu PK, Zhao Y, Soares MJ. Reductions in body weight and percent fat mass increase the vitamin D status of obese subjects: a systematic review and metaregression analysis. Nutr Res. 2016;36(3):201-13. doi: https://doi.org/10.1016/j.nutres.2015.11.013</mixed-citation><mixed-citation xml:lang="en">Pannu PK, Zhao Y, Soares MJ. Reductions in body weight and percent fat mass increase the vitamin D status of obese subjects: a systematic review and metaregression analysis. Nutr Res. 2016;36(3):201-13. doi: https://doi.org/10.1016/j.nutres.2015.11.013</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Zammouri J, Vatier C, Capel E, Auclair M, Storey-London C, et al. Molecular and Cellular Bases of Lipodystrophy Syndromes. Front. Endocrinol. 2022;12:803189. doi: https://doi.org/10.3389/fendo.2021.803189</mixed-citation><mixed-citation xml:lang="en">Zammouri J, Vatier C, Capel E, Auclair M, Storey-London C, et al. Molecular and Cellular Bases of Lipodystrophy Syndromes. Front. Endocrinol. 2022;12:803189. doi: https://doi.org/10.3389/fendo.2021.803189</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Funcke J-B, Scherer PE. Beyond adiponectin and leptin: Adipose tissue-derived mediators of inter-organ communication. J. Lipid Res. 2019;60:1648–1697. doi: https://doi.org/10.1194/jlr.R094060</mixed-citation><mixed-citation xml:lang="en">Funcke J-B, Scherer PE. Beyond adiponectin and leptin: Adipose tissue-derived mediators of inter-organ communication. J. Lipid Res. 2019;60:1648–1697. doi: https://doi.org/10.1194/jlr.R094060</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Mutt SJ, Hyppönen E, Saarnio J, Järvelin MR, Herzig KH. Vitamin D and adipose tissue-more than storage. Front Physiol. 2014;5:228. doi: https://doi.org/10.3389/fphys.2014.00228</mixed-citation><mixed-citation xml:lang="en">Mutt SJ, Hyppönen E, Saarnio J, Järvelin MR, Herzig KH. Vitamin D and adipose tissue-more than storage. Front Physiol. 2014;5:228. doi: https://doi.org/10.3389/fphys.2014.00228</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kong J, Li YC. Molecular mechanism of 1,25-dihydroxyvitamin D 3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Metab. 2006;290(5):E916-E924. doi: https://doi.org/10.1152/ajpendo.00410.2005</mixed-citation><mixed-citation xml:lang="en">Kong J, Li YC. Molecular mechanism of 1,25-dihydroxyvitamin D 3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Metab. 2006;290(5):E916-E924. doi: https://doi.org/10.1152/ajpendo.00410.2005</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Narvaez CJ, Simmons KM, Brunton J, Salinero A, Chittur S V., Welsh JE. Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J Cell Physiol. 2013. doi: https://doi.org/10.1002/jcp.24371</mixed-citation><mixed-citation xml:lang="en">Narvaez CJ, Simmons KM, Brunton J, Salinero A, Chittur S V., Welsh JE. Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J Cell Physiol. 2013. doi: https://doi.org/10.1002/jcp.24371</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Szymczak-Pajor I, Miazek K, Selmi A, Balcerczyk A, Śliwińska A. The Action of Vitamin D in Adipose Tissue: Is There the Link between Vitamin D Deficiency and Adipose Tissue-Related Metabolic Disorders? Int. J. Mol. Sci. 2022;23:956. doi: https://doi.org/10.3390/ijms23020956</mixed-citation><mixed-citation xml:lang="en">Szymczak-Pajor I, Miazek K, Selmi A, Balcerczyk A, Śliwińska A. The Action of Vitamin D in Adipose Tissue: Is There the Link between Vitamin D Deficiency and Adipose Tissue-Related Metabolic Disorders? Int. J. Mol. Sci. 2022;23:956. doi: https://doi.org/10.3390/ijms23020956</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y-C, Hsieh C-C, Kuo H-F, Tsai M-K, Yang S-N, Kuo C-H, et al. Effect of Vitamin D3 on Monocyte Chemoattractant Protein 1 Production in Monocytes and Macrophages. Acta Cardiol. Sin. 2014;30:144–150</mixed-citation><mixed-citation xml:lang="en">Wang Y-C, Hsieh C-C, Kuo H-F, Tsai M-K, Yang S-N, Kuo C-H, et al. Effect of Vitamin D3 on Monocyte Chemoattractant Protein 1 Production in Monocytes and Macrophages. Acta Cardiol. Sin. 2014;30:144–150</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Farhangi MA, Mesgari-Abbasi M, Hajiluian G, Nameni G, Shahabi P. Adipose Tissue Inflammation and Oxidative Stress: The Ameliorative Effects of Vitamin D. Inflammation. 2017;40:1688–1697. doi: https://doi.org/10.1007/s10753-017-0610-9-</mixed-citation><mixed-citation xml:lang="en">Farhangi MA, Mesgari-Abbasi M, Hajiluian G, Nameni G, Shahabi P. Adipose Tissue Inflammation and Oxidative Stress: The Ameliorative Effects of Vitamin D. Inflammation. 2017;40:1688–1697. doi: https://doi.org/10.1007/s10753-017-0610-9-</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Borges CC, Salles AF, Bringhenti I, Souza-Mello V, et al. Adverse effects of vitamin D deficiency on the Pi3k/Akt pathway and pancreatic islet morphology in diet-induced obese mice. Mol. Nutr. Food Res. 2015;60:346–357. doi: https://doi.org/10.1002/mnfr.201500398</mixed-citation><mixed-citation xml:lang="en">Borges CC, Salles AF, Bringhenti I, Souza-Mello V, et al. Adverse effects of vitamin D deficiency on the Pi3k/Akt pathway and pancreatic islet morphology in diet-induced obese mice. Mol. Nutr. Food Res. 2015;60:346–357. doi: https://doi.org/10.1002/mnfr.201500398</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Mirza I, Mohamed A, Deen H, Balaji S, Elsabbahi D, et al. Obesity-Associated Vitamin D Deficiency Correlates with Adipose Tissue DNA Hypomethylation, Inflammation, and Vascular Dysfunction. Int. J. Mol. Sci. 2022;23:14377. doi: https://doi.org/10.3390/ijms232214377</mixed-citation><mixed-citation xml:lang="en">Mirza I, Mohamed A, Deen H, Balaji S, Elsabbahi D, et al. Obesity-Associated Vitamin D Deficiency Correlates with Adipose Tissue DNA Hypomethylation, Inflammation, and Vascular Dysfunction. Int. J. Mol. Sci. 2022;23:14377. doi: https://doi.org/10.3390/ijms232214377</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Nimitphong H, Guo W, Holick MF, Fried .K, Lee M. Vitamin D Inhibits Adipokine Production and Inflammatory Signaling Through the Vitamin D Receptor in Human Adipocytes. Obesity. 2021;29:562–568. doi: https://doi.org/10.1002/oby.23109</mixed-citation><mixed-citation xml:lang="en">Nimitphong H, Guo W, Holick MF, Fried .K, Lee M. Vitamin D Inhibits Adipokine Production and Inflammatory Signaling Through the Vitamin D Receptor in Human Adipocytes. Obesity. 2021;29:562–568. doi: https://doi.org/10.1002/oby.23109</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Chang E, Kim Y. Vitamin D Insufficiency Exacerbates Adipose Tissue Macrophage Infiltration and Decreases AMPK/SIRT1 Activity in Obese Rats. Nutrients. 2017;9:338. doi: https://doi.org/10.3390/nu9040338</mixed-citation><mixed-citation xml:lang="en">Chang E, Kim Y. Vitamin D Insufficiency Exacerbates Adipose Tissue Macrophage Infiltration and Decreases AMPK/SIRT1 Activity in Obese Rats. Nutrients. 2017;9:338. doi: https://doi.org/10.3390/nu9040338</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Borges CC, Bringhenti I, Aguila MB, Mandarim-De-Lacerda CA. Vitamin D restriction enhances periovarian adipose tissue inflammation in a model of menopause. Climacteric. 2020;23:99–104. doi: https://doi.org/10.1080/13697137.2019.1597841</mixed-citation><mixed-citation xml:lang="en">Borges CC, Bringhenti I, Aguila MB, Mandarim-De-Lacerda CA. Vitamin D restriction enhances periovarian adipose tissue inflammation in a model of menopause. Climacteric. 2020;23:99–104. doi: https://doi.org/10.1080/13697137.2019.1597841</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Matthews DG, D’angelo J, Drelich J, Welsh J. Adipose-specific Vdr deletion alters body fat and enhances mammary epithelial density. J. Steroid Biochem. Mol. Biol. 2016;164:299–308. doi: https://doi.org/10.1016/j.jsbmb.2015.09.035</mixed-citation><mixed-citation xml:lang="en">Matthews DG, D’angelo J, Drelich J, Welsh J. Adipose-specific Vdr deletion alters body fat and enhances mammary epithelial density. J. Steroid Biochem. Mol. Biol. 2016;164:299–308. doi: https://doi.org/10.1016/j.jsbmb.2015.09.035</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Wu M, Lu L, Guo K, Lu J, Chen H. Vitamin D protects against high glucose-induced pancreatic β-cell dysfunction via AMPK-NLRP3 inflammasome pathway. Mol. Cell. Endocrinol. 2022;547:111596. doi: https://doi.org/10.1016/j.mce.2022.111596</mixed-citation><mixed-citation xml:lang="en">Wu M, Lu L, Guo K, Lu J, Chen H. Vitamin D protects against high glucose-induced pancreatic β-cell dysfunction via AMPK-NLRP3 inflammasome pathway. Mol. Cell. Endocrinol. 2022;547:111596. doi: https://doi.org/10.1016/j.mce.2022.111596</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Huang J, An Q, Ju BM, Zhang J, Fan P, He L, Wang L. Role of vitamin D/VDR nuclear translocation in down-regulation of NF-κB/NLRP3/caspase-1 axis in lupus nephritis. Int Immunopharmacol. 2021;100:108131. doi: https://doi.org/10.1016/j.intimp.2021.108131</mixed-citation><mixed-citation xml:lang="en">Huang J, An Q, Ju BM, Zhang J, Fan P, He L, Wang L. Role of vitamin D/VDR nuclear translocation in down-regulation of NF-κB/NLRP3/caspase-1 axis in lupus nephritis. Int Immunopharmacol. 2021;100:108131. doi: https://doi.org/10.1016/j.intimp.2021.108131</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Prentki M, Peyot ML, Masiello P, Madiraju SRM. Nutrient-Induced Metabolic Stress, Adaptation, Detoxification, and Toxicity in the Pancreatic beta-Cell. Diabetes. 2020;69:279–290. doi: https://doi.org/10.2337/dbi19-0014</mixed-citation><mixed-citation xml:lang="en">Prentki M, Peyot ML, Masiello P, Madiraju SRM. Nutrient-Induced Metabolic Stress, Adaptation, Detoxification, and Toxicity in the Pancreatic beta-Cell. Diabetes. 2020;69:279–290. doi: https://doi.org/10.2337/dbi19-0014</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Mitri J, Pittas AG. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2014;43(1):205-32. doi: https://doi.org/10.1016/j.ecl.2013.09.010</mixed-citation><mixed-citation xml:lang="en">Mitri J, Pittas AG. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2014;43(1):205-32. doi: https://doi.org/10.1016/j.ecl.2013.09.010</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Wolden-Kirk H, Overbergh L, Gysemans C, Brusgaard K, Naamane N, et al. Unraveling the effects of 1,25OH2D3 on global gene expression in pancreatic islets. J. Steroid Biochem. Mol. Biol. 2013;136:68–79. doi: https://doi.org/10.1016/j.jsbmb.2012.10.017</mixed-citation><mixed-citation xml:lang="en">Wolden-Kirk H, Overbergh L, Gysemans C, Brusgaard K, Naamane N, et al. Unraveling the effects of 1,25OH2D3 on global gene expression in pancreatic islets. J. Steroid Biochem. Mol. Biol. 2013;136:68–79. doi: https://doi.org/10.1016/j.jsbmb.2012.10.017</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Doyle ME, Egan JM. Pharmacological Agents That Directly Modulate Insulin Secretion. Pharmacol. Rev. 2003;55:105–131. doi: https://doi.org/10.1124/pr.55.1.7</mixed-citation><mixed-citation xml:lang="en">Doyle ME, Egan JM. Pharmacological Agents That Directly Modulate Insulin Secretion. Pharmacol. Rev. 2003;55:105–131. doi: https://doi.org/10.1124/pr.55.1.7</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Wu J, Atkins A, Downes M, Wei Z. Vitamin D in Diabetes: Uncovering the Sunshine Hormone’s Role in Glucose Metabolism and Beyond. Nutrients. 2023;15(8):1997. doi: https://doi.org/10.3390/nu15081997</mixed-citation><mixed-citation xml:lang="en">Wu J, Atkins A, Downes M, Wei Z. Vitamin D in Diabetes: Uncovering the Sunshine Hormone’s Role in Glucose Metabolism and Beyond. Nutrients. 2023;15(8):1997. doi: https://doi.org/10.3390/nu15081997</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Norman AW, Frankel BJ, Heldt AM, Grodsky GM. Vitamin D Deficiency Inhibits Pancreatic Secretion of Insulin. Science. 1980;209:823–825. doi: https://doi.org/10.1126/science.6250216</mixed-citation><mixed-citation xml:lang="en">Norman AW, Frankel BJ, Heldt AM, Grodsky GM. Vitamin D Deficiency Inhibits Pancreatic Secretion of Insulin. Science. 1980;209:823–825. doi: https://doi.org/10.1126/science.6250216</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Bourlon PM, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J. Endocrinol. 1999;160:87–95. doi: https://doi.org/10.1677/joe.0.1600087</mixed-citation><mixed-citation xml:lang="en">Bourlon PM, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J. Endocrinol. 1999;160:87–95. doi: https://doi.org/10.1677/joe.0.1600087</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Maestro B, Campión J, Dávila N, Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000. doi: https://doi.org/10.1507/endocrj.47.383</mixed-citation><mixed-citation xml:lang="en">Maestro B, Campión J, Dávila N, Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000. doi: https://doi.org/10.1507/endocrj.47.383</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, Carlberg C. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol. 2005;349(2):248–60</mixed-citation><mixed-citation xml:lang="en">Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, Carlberg C. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol. 2005;349(2):248–60</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Ojuka EO. Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc Nutr Soc. 2004;63(2):275–8.; Wright DC, Hucker KA, Holloszy JO, Han DH. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes. 2004;53(2):330–5</mixed-citation><mixed-citation xml:lang="en">Ojuka EO. Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc Nutr Soc. 2004;63(2):275–8.; Wright DC, Hucker KA, Holloszy JO, Han DH. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes. 2004;53(2):330–5</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Draznin B, Sussman K, Kao M, Lewis D, Sherman N. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem. 1987;262(30):14385–8</mixed-citation><mixed-citation xml:lang="en">Draznin B, Sussman K, Kao M, Lewis D, Sherman N. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem. 1987;262(30):14385–8</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Uryash A, Umlas J, Mijares A, Adams JA, Lopez JR. Enhancing Muscle Intracellular Ca2+ Homeostasis and Glucose Uptake: Passive Pulsatile Shear Stress Treatment in Type 2 Diabetes. Biomedicines. 2023;11(10):2596. doi: https://doi.org/10.3390/biomedicines11102596</mixed-citation><mixed-citation xml:lang="en">Uryash A, Umlas J, Mijares A, Adams JA, Lopez JR. Enhancing Muscle Intracellular Ca2+ Homeostasis and Glucose Uptake: Passive Pulsatile Shear Stress Treatment in Type 2 Diabetes. Biomedicines. 2023;11(10):2596. doi: https://doi.org/10.3390/biomedicines11102596</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Li D, Fu N, Wu H. Effect of vitamin D supplementation on various parameters in patients with non-alcoholic fatty liver disease: An updated meta-analysis. Clin Exp Hepatol. 2023;9(4):396-404. doi: https://doi.org/10.5114/ceh.2023.133194</mixed-citation><mixed-citation xml:lang="en">Li D, Fu N, Wu H. Effect of vitamin D supplementation on various parameters in patients with non-alcoholic fatty liver disease: An updated meta-analysis. Clin Exp Hepatol. 2023;9(4):396-404. doi: https://doi.org/10.5114/ceh.2023.133194</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Zemel MB. Nutritional and endocrine modulation of intracellular calcium: Implications in obesity, insulin resistance and hypertension. In: Molecular and Cellular Biochemistry. 1998. doi: https://doi.org/10.1023/A:1006880708475</mixed-citation><mixed-citation xml:lang="en">Zemel MB. Nutritional and endocrine modulation of intracellular calcium: Implications in obesity, insulin resistance and hypertension. In: Molecular and Cellular Biochemistry. 1998. doi: https://doi.org/10.1023/A:1006880708475</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Reusch JE, Begum N, Sussman KE, Draznin B. Regulation of GLUT-4 Phosphorylation by Intracellular Calcium in Adipocytes*. Endocrinology. 1991;129(6):3269-3273. doi: https://doi.org/10.1210/endo-129-6-3269</mixed-citation><mixed-citation xml:lang="en">Reusch JE, Begum N, Sussman KE, Draznin B. Regulation of GLUT-4 Phosphorylation by Intracellular Calcium in Adipocytes*. Endocrinology. 1991;129(6):3269-3273. doi: https://doi.org/10.1210/endo-129-6-3269</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Reis JP, von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, Parathyroid Hormone Levels, and the Prevalence of Metabolic Syndrome in Community-Dwelling Older Adults. Diabetes Care. 2007;30(6):1549-1555. doi: https://doi.org/10.2337/dc06-2438</mixed-citation><mixed-citation xml:lang="en">Reis JP, von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, Parathyroid Hormone Levels, and the Prevalence of Metabolic Syndrome in Community-Dwelling Older Adults. Diabetes Care. 2007;30(6):1549-1555. doi: https://doi.org/10.2337/dc06-2438</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Vaidya A, Williams JS. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism. 2012. doi: https://doi.org/10.1016/j.metabol.2011.09.007</mixed-citation><mixed-citation xml:lang="en">Vaidya A, Williams JS. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism. 2012. doi: https://doi.org/10.1016/j.metabol.2011.09.007</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000. doi: https://doi.org/10.1093/ajcn/72.3.690</mixed-citation><mixed-citation xml:lang="en">Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000. doi: https://doi.org/10.1093/ajcn/72.3.690</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Pathak K, Soares MJ, Calton EK, Zhao Y, Hallett J. Vitamin D supplementation and body weight status: a systematic review and meta‐analysis of randomized controlled trials. Obes Rev. 2014;15(6):528-537. doi: https://doi.org/10.1111/obr.12162</mixed-citation><mixed-citation xml:lang="en">Pathak K, Soares MJ, Calton EK, Zhao Y, Hallett J. Vitamin D supplementation and body weight status: a systematic review and meta‐analysis of randomized controlled trials. Obes Rev. 2014;15(6):528-537. doi: https://doi.org/10.1111/obr.12162</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Golzarand M, Hollis BW, Mirmiran P, Wagner CL, Shab-Bidar S. Vitamin D supplementation and body fat mass: a systematic review and meta-analysis. Eur J Clin Nutr. 2018;72(10):1345-1357. doi: https://doi.org/10.1038/s41430-018-0132-z</mixed-citation><mixed-citation xml:lang="en">Golzarand M, Hollis BW, Mirmiran P, Wagner CL, Shab-Bidar S. Vitamin D supplementation and body fat mass: a systematic review and meta-analysis. Eur J Clin Nutr. 2018;72(10):1345-1357. doi: https://doi.org/10.1038/s41430-018-0132-z</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Perna S. Is vitamin d supplementation useful for weight loss programs? A systematic review and meta-analysis of randomized controlled trials. Med. 2019. doi: https://doi.org/10.3390/medicina55070368</mixed-citation><mixed-citation xml:lang="en">Perna S. Is vitamin d supplementation useful for weight loss programs? A systematic review and meta-analysis of randomized controlled trials. Med. 2019. doi: https://doi.org/10.3390/medicina55070368</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Ma K, Wei SQ, Bi WG, Weiler HA, Wen SW. Effect of Vitamin D Supplementation in Early Life on Children’s Growth and Body Composition: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2021;13(2):524. doi: https://doi.org/10.3390/nu13020524</mixed-citation><mixed-citation xml:lang="en">Ma K, Wei SQ, Bi WG, Weiler HA, Wen SW. Effect of Vitamin D Supplementation in Early Life on Children’s Growth and Body Composition: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2021;13(2):524. doi: https://doi.org/10.3390/nu13020524</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Xue J, Schoenrock SA, Valdar W, Tarantino LM, Ideraabdullah FY. Maternal vitamin D depletion alters DNA methylation at imprinted loci in multiple generations. Clin Epigenetics. 2016. doi: https://doi.org/10.1186/s13148-016-0276-4</mixed-citation><mixed-citation xml:lang="en">Xue J, Schoenrock SA, Valdar W, Tarantino LM, Ideraabdullah FY. Maternal vitamin D depletion alters DNA methylation at imprinted loci in multiple generations. Clin Epigenetics. 2016. doi: https://doi.org/10.1186/s13148-016-0276-4</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Lemieux P, Weisnagel SJ, Caron AZ, et al. Effects of 6-month vitamin D supplementation on insulin sensitivity and secretion: a randomised, placebo-controlled trial. Eur J Endocrinol. 2019;181(3):287-299. doi: https://doi.org/10.1530/EJE-19-0156</mixed-citation><mixed-citation xml:lang="en">Lemieux P, Weisnagel SJ, Caron AZ, et al. Effects of 6-month vitamin D supplementation on insulin sensitivity and secretion: a randomised, placebo-controlled trial. Eur J Endocrinol. 2019;181(3):287-299. doi: https://doi.org/10.1530/EJE-19-0156</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Oosterwerff MM, Eekhoff EM, Van Schoor NM, Boeke AJP, Nanayakkara P, et al. Effect of moderate-dose vitamin D supplementation on insulin sensitivity in vitamin D–deficient non-Western immigrants in the Netherlands: A randomized placebo-controlled trial. Am. J. Clin. Nutr. 2014;100:152–160. doi: https://doi.org/10.3945/ajcn.113.069260</mixed-citation><mixed-citation xml:lang="en">Oosterwerff MM, Eekhoff EM, Van Schoor NM, Boeke AJP, Nanayakkara P, et al. Effect of moderate-dose vitamin D supplementation on insulin sensitivity in vitamin D–deficient non-Western immigrants in the Netherlands: A randomized placebo-controlled trial. Am. J. Clin. Nutr. 2014;100:152–160. doi: https://doi.org/10.3945/ajcn.113.069260</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Nazarian S, Peter JVS, Boston RC, Jones SA, Mariash CN. Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose. Transl. Res. 2011;158:276–281. doi: https://doi.org/10.1016/j.trsl.2011.05.002</mixed-citation><mixed-citation xml:lang="en">Nazarian S, Peter JVS, Boston RC, Jones SA, Mariash CN. Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose. Transl. Res. 2011;158:276–281. doi: https://doi.org/10.1016/j.trsl.2011.05.002</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol. Metab. Syndr. 2013;5:8. doi: https://doi.org/10.1186/1758-5996-5-8</mixed-citation><mixed-citation xml:lang="en">Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol. Metab. Syndr. 2013;5:8. doi: https://doi.org/10.1186/1758-5996-5-8</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Hanafy AS, Elkatawy HA. Beneficial Effects of Vitamin D on Insulin Sensitivity, Blood Pressure, Abdominal Subcutaneous Fat Thickness, and Weight Loss in Refractory Obesity. Clin. Diabetes. 2018;36:217–225. doi: https://doi.org/10.2337/cd17-0099</mixed-citation><mixed-citation xml:lang="en">Hanafy AS, Elkatawy HA. Beneficial Effects of Vitamin D on Insulin Sensitivity, Blood Pressure, Abdominal Subcutaneous Fat Thickness, and Weight Loss in Refractory Obesity. Clin. Diabetes. 2018;36:217–225. doi: https://doi.org/10.2337/cd17-0099</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int. J. Clin. Pr. 2003;57:258–261. doi: https://doi.org/10.1111/j.1742-1241.2003.tb10480.x</mixed-citation><mixed-citation xml:lang="en">Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int. J. Clin. Pr. 2003;57:258–261. doi: https://doi.org/10.1111/j.1742-1241.2003.tb10480.x</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Asemi Z, Karamali M, Esmaillzadeh A. Effects of calcium–vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: A randomised placebo-controlled trial. Diabetologia. 2014;57:1798–1806. doi: https://doi.org/10.1007/s00125-014-3293-x</mixed-citation><mixed-citation xml:lang="en">Asemi Z, Karamali M, Esmaillzadeh A. Effects of calcium–vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: A randomised placebo-controlled trial. Diabetologia. 2014;57:1798–1806. doi: https://doi.org/10.1007/s00125-014-3293-x</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Tan H, Tang J, Li J, Chong W, et al. Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis. Diabetes Care. 2020;43(7):1650-1658. doi: https://doi.org/10.2337/dc19-1708</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Tan H, Tang J, Li J, Chong W, et al. Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis. Diabetes Care. 2020;43(7):1650-1658. doi: https://doi.org/10.2337/dc19-1708</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Pittas AG, Kawahara T, Jorde R, Dawson-Hughes B, Vickery EM, et al. Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes : A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials. Ann Intern Med. 2023;176(3):355-363. doi: https://doi.org/10.7326/M22-3018</mixed-citation><mixed-citation xml:lang="en">Pittas AG, Kawahara T, Jorde R, Dawson-Hughes B, Vickery EM, et al. Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes : A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials. Ann Intern Med. 2023;176(3):355-363. doi: https://doi.org/10.7326/M22-3018</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. Vitamin D Supplementation, Glycemic Control, and Insulin Resistance in Prediabetics: A Meta-Analysis. J Endocr Soc. 2018;2(7):687-709. doi: https://doi.org/10.1210/js.2017-00472</mixed-citation><mixed-citation xml:lang="en">Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. Vitamin D Supplementation, Glycemic Control, and Insulin Resistance in Prediabetics: A Meta-Analysis. J Endocr Soc. 2018;2(7):687-709. doi: https://doi.org/10.1210/js.2017-00472</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Lei X, Zhou Q, Wang Y, Fu S, Li Z, Chen Q. Serum and supplemental vitamin D levels and insulin resistance in T2DM populations: a meta-analysis and systematic review. Sci Rep. 2023;13(1):12343. doi: https://doi.org/10.1038/s41598-023-39469-9</mixed-citation><mixed-citation xml:lang="en">Lei X, Zhou Q, Wang Y, Fu S, Li Z, Chen Q. Serum and supplemental vitamin D levels and insulin resistance in T2DM populations: a meta-analysis and systematic review. Sci Rep. 2023;13(1):12343. doi: https://doi.org/10.1038/s41598-023-39469-9</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis. J Clin Endocrinol Metab. 2017;102(9):3097-3110. doi: https://doi.org/10.1210/jc.2017-01024</mixed-citation><mixed-citation xml:lang="en">Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis. J Clin Endocrinol Metab. 2017;102(9):3097-3110. doi: https://doi.org/10.1210/jc.2017-01024</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang B, Zhao W, Tu J, Wang X, Hao Y, et al. The relationship between serum 25-hydroxyvitamin D concentration and type 2 diabetic peripheral neuropathy: A systematic review and a meta-analysis. Medicine (Baltimore). 2019;98(48):e18118. doi: https://doi.org/10.1097/MD.0000000000018118</mixed-citation><mixed-citation xml:lang="en">Zhang B, Zhao W, Tu J, Wang X, Hao Y, et al. The relationship between serum 25-hydroxyvitamin D concentration and type 2 diabetic peripheral neuropathy: A systematic review and a meta-analysis. Medicine (Baltimore). 2019;98(48):e18118. doi: https://doi.org/10.1097/MD.0000000000018118</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Azmi S, Ferdousi M, Kalteniece A, Al-Muhannadi H, Al-Mohamedi A, et al. Diagnosing and managing diabetic somatic and autonomic neuropathy. Ther Adv Endocrinol Metab. 2019;10:2042018819826890. doi: https://doi.org/10.1177/2042018819826890</mixed-citation><mixed-citation xml:lang="en">Azmi S, Ferdousi M, Kalteniece A, Al-Muhannadi H, Al-Mohamedi A, et al. Diagnosing and managing diabetic somatic and autonomic neuropathy. Ther Adv Endocrinol Metab. 2019;10:2042018819826890. doi: https://doi.org/10.1177/2042018819826890</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Huang B, Wen W, Ye S. Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis. Front Endocrinol (Lausanne). 2022;13:880930. doi: https://doi.org/10.3389/fendo.2022.880930</mixed-citation><mixed-citation xml:lang="en">Huang B, Wen W, Ye S. Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis. Front Endocrinol (Lausanne). 2022;13:880930. doi: https://doi.org/10.3389/fendo.2022.880930</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou T, Shen L, Li Z, Jia J, Xing H, Wang N, Jiao Q, Fan Y. Severe 25-Hydroxyvitamin D Deficiency May Predict Poor Renal Outcomes in Patients With Biopsy-Proven Diabetic Nephropathy. Front Endocrinol (Lausanne). 2022;13:871571. doi: https://doi.org/10.3389/fendo.2022.871571</mixed-citation><mixed-citation xml:lang="en">Zhou T, Shen L, Li Z, Jia J, Xing H, Wang N, Jiao Q, Fan Y. Severe 25-Hydroxyvitamin D Deficiency May Predict Poor Renal Outcomes in Patients With Biopsy-Proven Diabetic Nephropathy. Front Endocrinol (Lausanne). 2022;13:871571. doi: https://doi.org/10.3389/fendo.2022.871571</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Мельниченко Г.А., Мокрышева Н.Г., Пигарова Е.А., Поваляева А.А., и др. Проект федеральных клинических рекомендаций по диагностике, лечению и профилактике дефицита витамина D // Остеопороз и остеопатии. — 2021. — Т. 24. — №4. — С. 4-26. doi: https://doi.org/10.14341/osteo12937</mixed-citation><mixed-citation xml:lang="en">Dedov II, Mel’nichenko GA, Mokrysheva NG, Pigarova EA, Povaliaeva AA, et al. Draft federal clinical practice guidelines for the diagnosis, treatment, and prevention of vitamin D deficiency. Osteoporosis and Bone Diseases. 2021;24(4):4-26. (In Russ.) doi: https://doi.org/10.14341/osteo12937</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
